US2006117407A1PendingUtilityA1
Method of producing transgenic maize using direct transformation of commercially important genotypes
Est. expiryAug 24, 2010(expired)· nominal 20-yr term from priority
Inventors:Michael G. KozielNalini M. DesaiKelly S. LewisVance Cary KramerGregory W. WarrenSteve EvolaLyle D. CrosslandMartha S. WrightEllis J. MerlinKaren L. LaunisSteven RothsteinCindy BoyceJohn L. DawsonErik DunderGary M. PaceJan SuttieNadine CarozziAnnick Jeanne De FramondJames LinderRobert Lynn MillerBruce SkillingsAlan MouselAlbert R. HornbrookChristopher ClucasMoez MeghjiAndreas TannerFrancis CassagneGilles PolliniTerry R. ColbertFrancis Cammack
C12N 15/8286Y02A40/146C07K 14/325C12N 9/12C12N 9/88
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods for transformation of maize with nucleic acid sequences of interest are disclosed. The method involves subjecting immature zygotic embryos or Type I callus to high velocity microprojectile bombardment. The method is capable of producing transformed maize lines of commercial importance and their hybrid combinations.
Claims
exact text as granted — not AI-modified1 - 82 . (canceled)
82 . A fertile transgenic Zea mays plant comprising a preselected DNA sequence encoding a Bacillus thuringiensis endotoxin, wherein the preselected DNA sequence is adjusted to be more efficiently expressed in maize than the native B. thuringiensis DNA sequence encoding said endotoxin, and wherein said preselected DNA is heritable.
83 . The transgenic Zea mays plant of claim 82 wherein the preselected DNA sequence comprises an increased G+C content of the degenerate third base of the codons.
84 . The transgenic Zea mays plant of claim 82 wherein the preselected DNA sequence comprises a sequence encoding the HD73 endotoxin of Bacillus thuringiensis.
85 . A seed produced by the transgenic Zea mays plant of claim 82 , 83 or 84 which comprises said preselected DNA sequence.
86 . The transgenic Zea mays plant of claim 82 wherein the preselected DNA sequence encodes a truncated Bacillus thuringiensis endotoxin.
87 . The transgenic Zea mays plant of claim 82 wherein the preselected DNA sequence comprises a promoter.
88 . A fertile inbred transgenic Zea mays plant comprising a preselected DNA sequence encoding a Bacillus thuringiensis endotoxin, wherein the preselected DNA sequence is adjusted to be more efficiently expressed in maize than the native B. thuringiensis DNA sequence encoding said endotoxin and wherein the preselected DNA sequence is heritable.
89 . A fertile hybrid transgenic Zea mays plant comprising a preselected DNA sequence encoding a Bacillus thuringiensis endotoxin, wherein the preselected DNA sequence is adjusted to be more efficiently expressed in maize than the native B. thuringiensis DNA sequence encoding said endotoxin, and wherein the preselected DNA sequence is heritable.
90 . A fertile transgenic Zea mays plant comprising a preselected heritable DNA sequence encoding a Bacillus thuringiensis endotoxin, wherein the preselected DNA sequence is adjusted to be more efficiently expressed in maize than the native B. thuringiensis DNA sequence encoding said endotoxin, and wherein the preselected DNA sequence further comprises a selectable marker gene or a reporter gene.
91 . The transgenic Zea mays plant of claim 90 wherein the preselected DNA sequence comprises a sequence encoding the HD73 endotoxin of Bacillus thuringiensis.
92 . The transgenic Zea mays plant of claim 90 wherein the preselected DNA sequence comprises a sequence encoding the HD1 endotoxin of Bacillus thuringiensis.
93 . A seed produced by the transgenic Zea mays plant of claim 90 , 91 or 92 which comprises said preselected DNA sequence.
94 . The transgenic Zea mays plant of claim 90 wherein the DNA sequence encodes a truncated Bacillus thuringiensis endotoxin.
95 . The transgenic Zea mays plant of claim 90 wherein the preselected DNA sequence further comprises a promoter operably linked to said DNA sequence encoding said endotoxin and a promoter operably linked to said selectable marker gene.
96 . A fertile inbred transgenic Zea mays plant comprising a preselected heritable DNA sequence encoding a Bacillus thuringiensis endotoxin, wherein the preselected DNA sequence is adjusted to be more efficiently expressed in maize than the native B. thuringiensis DNA sequence encoding said endotoxin, and wherein the preselected DNA sequence further comprises a selectable marker gene or a reporter gene.
97 . A fertile hybrid transgenic Zea mays plant comprising a preselected heritable DNA sequence encoding a Bacillus thuringiensis endotoxin, wherein the preselected DNA sequence is adjusted to be more efficiently expressed in maize than the native B. thuringiensis DNA sequence encoding said endotoxin, and wherein the preselected DNA sequence further comprises a selectable marker gene or a reporter gene.
98 . The transgenic Zea mays plant of claim 90 wherein the selectable marker gene confers resistance or tolerance to a compound selected from the group consisting of hygromycin, sethoxydim, haloxyfop, glyphosate, methotrexate, imidazoline, sulfonylurea, triazolopyrimidine, s-triazine, bromoxynil, phosphinothricin, kanamycin, G418, 2,2-dichloropropionic acid and neomycin.
99 . The transgenic plant of claim 98 wherein the compound is phosphinothricin.
100 . The transgenic plant of claim 98 wherein the compound is glyphosate.
101 . The transgenic plant of claim 98 wherein the compound is kanamycin.
102 . The transgenic plant of claim 98 wherein the compound is hygromycin.
103 . The transgenic plant of claim 90 wherein the DNA encoding the Bacillus thuringiensis endotoxin is fused in frame with said selectable marker or reporter gene.
104 . The inbred transgenic plant of claim 96 wherein the DNA encodes a truncated Bacillus thuringiensis endotoxin.
105 . The hybrid transgenic plant of claim 99 wherein the DNA encodes a truncated Bacillus thuringiensis endotoxin.
106 . The transgenic plant of claim 86 , 104 or 105 wherein the truncated Bacillus thuringiensis endotoxin comprises about the N-terminal 50% of the endotoxin.
107 . The transgenic plant of claim 82 or 90 wherein the preselected DNA further encodes a protease inhibitor.
108 . The transgenic plant of claim 87 or 95 wherein the preselected DNA sequence further comprises the maize AdhIS first intron or the maize Shrunken-2 first intron positioned between the promoter and the DNA encoding said endotoxin.
109 . The transgenic plant of claim 87 or 95 wherein the preselected DNA sequence further comprises a manopine synthase promoter, a nopaline synthase promoter or an octopine synthase promoter.
110 . The transgenic plant of claim 87 or 95 wherein the promoter is the CaMV 35S or 19S promoter.
111 . A population of plants obtained by breeding the transgenic plants of claim 82 or 95 wherein the preselected DNA sequence is transmitted by Mendelian inheritance through both male and female parent plants.
112 . An inbred insect-resistant transgenic Zea mays plant prepared by a process comprising:
(a) crossing a fertile transgenic Zea mays plant comprising a preselected DNA sequence encoding a Bacillus thuringiensis endotoxin, wherein the preselected DNA sequence is adjusted to be more efficiently expressed in maize than the B. thuringiensis DNA sequence encoding said endotoxin, and wherein said DNA sequence is heritable, with a member of a second inbred Zea mays line; (b) recovering insect-resistant transgenic progeny plants from said cross; (c) back-crossing one of the transgenic progeny plants with a member of said second inbred line; (d) recovering insect-resistant transgenic progeny plants from said cross; and (e) repeating steps (b) and (c) to obtain said inbred plant.
113 . The inbred transgenic Zea mays plant of claim 112 wherein said preselected DNA sequence encodes a truncated Bacillus thuringiensis endotoxin.
114 . A transgenic insect-resistant hybrid plant prepared by crossing the inbred plant of claim 112 or 113 with an inbred Zea mays line, and recovering said hybrid plant.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.